Emergency Department-Initiated Medications for Alcohol Use Disorder

In the MAUD component, some participants will receive oral Naltrexone in the ED.

In the MAUD component, some participants will receive a dose of XR-NTX (injection) in the ED.

Brief Negotiation Interview (BNI) has four key components: (1) permission to discuss substance use, (2) feedback on the health consequences of ongoing substance use, including making a connection between the ED visit and substance use, (3) motivational enhancement, and (4) negotiation and advice.

In the MAUD component, ancillary treatment with gabapentin will be provided.